169 related articles for article (PubMed ID: 12847110)
1. The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor.
Merkulova-Rainon T; England P; Ding S; Demerens C; Tobelem G
J Biol Chem; 2003 Sep; 278(39):37400-8. PubMed ID: 12847110
[TBL] [Abstract][Full Text] [Related]
2. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
[TBL] [Abstract][Full Text] [Related]
3. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells.
Wajih N; Sane DC
Blood; 2003 Mar; 101(5):1857-63. PubMed ID: 12406896
[TBL] [Abstract][Full Text] [Related]
4. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.
Rubin JS; Day RM; Breckenridge D; Atabey N; Taylor WG; Stahl SJ; Wingfield PT; Kaufman JD; Schwall R; Bottaro DP
J Biol Chem; 2001 Aug; 276(35):32977-83. PubMed ID: 11435444
[TBL] [Abstract][Full Text] [Related]
6. Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains.
Holmes O; Pillozzi S; Deakin JA; Carafoli F; Kemp L; Butler PJ; Lyon M; Gherardi E
J Mol Biol; 2007 Mar; 367(2):395-408. PubMed ID: 17258232
[TBL] [Abstract][Full Text] [Related]
7. Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor.
Zlot C; Ingle G; Hongo J; Yang S; Sheng Z; Schwall R; Paoni N; Wang F; Peale FV; Gerritsen ME
J Biol Chem; 2003 Nov; 278(48):47654-9. PubMed ID: 14500721
[TBL] [Abstract][Full Text] [Related]
8. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor.
Mizuno K; Inoue H; Hagiya M; Shimizu S; Nose T; Shimohigashi Y; Nakamura T
J Biol Chem; 1994 Jan; 269(2):1131-6. PubMed ID: 8288571
[TBL] [Abstract][Full Text] [Related]
9. Recombinant kringle 5 from plasminogen antagonises hepatocyte growth factor-mediated signalling.
Ansell PJ; Zhang H; Davidson DJ; Harlan JE; Xue J; Brodjian S; Lesniewski R; McKeegan E
Eur J Cancer; 2010 Mar; 46(5):966-73. PubMed ID: 20061137
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
Montesano R; Soriano JV; Malinda KM; Ponce ML; Bafico A; Kleinman HK; Bottaro DP; Aaronson SA
Cell Growth Differ; 1998 May; 9(5):355-65. PubMed ID: 9607557
[TBL] [Abstract][Full Text] [Related]
11. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo.
Hartmann G; Prospero T; Brinkmann V; Ozcelik C; Winter G; Hepple J; Batley S; Bladt F; Sachs M; Birchmeier C; Birchmeier W; Gherardi E
Curr Biol; 1998 Jan; 8(3):125-34. PubMed ID: 9443912
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
Nakamura T
Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.
Bussolino F; Di Renzo MF; Ziche M; Bocchietto E; Olivero M; Naldini L; Gaudino G; Tamagnone L; Coffer A; Comoglio PM
J Cell Biol; 1992 Nov; 119(3):629-41. PubMed ID: 1383237
[TBL] [Abstract][Full Text] [Related]
14. Domain structure of hepatocyte growth factor/scatter factor (HGF/SF).
Gherardi E; Hartmann G; Hepple J; Chirgadze D; Srinivasan N; Blundell T
Ciba Found Symp; 1997; 212():84-93; discussion 93-104. PubMed ID: 9524765
[TBL] [Abstract][Full Text] [Related]
15. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.
Sakata H; Stahl SJ; Taylor WG; Rosenberg JM; Sakaguchi K; Wingfield PT; Rubin JS
J Biol Chem; 1997 Apr; 272(14):9457-63. PubMed ID: 9083085
[TBL] [Abstract][Full Text] [Related]
16. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor.
Date K; Matsumoto K; Shimura H; Tanaka M; Nakamura T
FEBS Lett; 1997 Dec; 420(1):1-6. PubMed ID: 9450538
[TBL] [Abstract][Full Text] [Related]
17. HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro.
Ding S; Merkulova-Rainon T; Han ZC; Tobelem G
Blood; 2003 Jun; 101(12):4816-22. PubMed ID: 12595309
[TBL] [Abstract][Full Text] [Related]
18. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.
Hartmann G; Naldini L; Weidner KM; Sachs M; Vigna E; Comoglio PM; Birchmeier W
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11574-8. PubMed ID: 1280830
[TBL] [Abstract][Full Text] [Related]
19. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
EXS; 1993; 65():311-28. PubMed ID: 8380739
[TBL] [Abstract][Full Text] [Related]
20. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
